We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Events
» Quality
Date Range:
All
Next 7 Days
Next Month
Next 3 Months
Next 6 Months
Archives
Quality
Webinar
EU-MDR: Are You Ready? An Exclusive Three-Part FDAnews Webinar Series
Read More
Data Integrity in the COVID-19 Era and Beyond: A Three-Part FDAnews/CenterWatch Virtual Conference Series
Read More
Webinar
Jul. 28, 2022
–
Jul. 28, 2022
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
Read More
Webinar
Jul. 28, 2022
–
Jul. 28, 2022
Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does
Read More
Webinar
Aug. 02, 2022
–
Aug. 02, 2022
Medical Device Cybersecurity: Understand the Latest Developments
Read More
Conference
Nov. 16, 2022
–
Nov. 18, 2022
17th Annual FDA Inspections Summit
Read More
Download iCal
Subscribe to Calendar
Upcoming Events
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
27
Jul
Applying the Lessons of the Pandemic to Your Upcoming Trial
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
28
Jul
Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FX Receives FDA Clearance for Its FX V135 Shoulder Arthroplasty Platform
FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants
FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek
Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
